Clinical trial
Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Increase for Efficiency of Intraoperative Neural Monitoring in the Thyroid Surgery
NCT03634956 is registered in ClinicalTrials.gov with Lütfiye Nuri Burat Government Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Increase for Efficiency of Intraoperative Neural Monitoring in the Thyroid Surgery
- Lead sponsor
- Lütfiye Nuri Burat Government Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 14, 2018
- Completion date
- March 14, 2019
- Enrollment
- 2 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent laryngeal nerve, vocal cord paralysis